Asymchem Laboratories Tianjin Co (HKSE:06821) Accounts Payable & Accrued Expense : HK$1,245 Mil (As of Mar. 2025)

View and export this data going back to 2021. Start your Free Trial

What is Asymchem Laboratories Tianjin Co Accounts Payable & Accrued Expense?

Asymchem Laboratories Tianjin Co's quarterly accounts payable & accrued expense increased from Sep. 2024 (HK$1,418 Mil) to Dec. 2024 (HK$1,492 Mil) but then declined from Dec. 2024 (HK$1,492 Mil) to Mar. 2025 (HK$1,245 Mil).

Asymchem Laboratories Tianjin Co's annual accounts payable & accrued expense declined from Dec. 2022 (HK$2,090 Mil) to Dec. 2023 (HK$1,683 Mil) and declined from Dec. 2023 (HK$1,683 Mil) to Dec. 2024 (HK$1,492 Mil).

Asymchem Laboratories Tianjin Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Asymchem Laboratories Tianjin Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Asymchem Laboratories Tianjin Co Accounts Payable & Accrued Expense Chart

Asymchem Laboratories Tianjin Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

975.07

2,056.80

2,089.58

1,682.94

1,491.61

Asymchem Laboratories Tianjin Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															1,578.98	1,732.07	1,418.33	1,491.61	1,244.86

Asymchem Laboratories Tianjin Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Asymchem Laboratories Tianjin Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Asymchem Laboratories Tianjin Co Ltd (HKSE:06821) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

7K90:Germany 002821:China

Address

No. 6 Dongting Third Street, Economic and Technological Development Zone, Tianjin, CHN, 300457

Website

https://www.asymchem.com

Asymchem Laboratories Tianjin Co Ltd is a China-based company, a technology-driven provider of Contract Development manufacturing organization solutions throughout the drug development and manufacturing process. The Group provides clinical-stage CDMO solutions, commercial-stage CDMO solutions, and emerging services. Its operations relate to contract development and manufacturing which focuses on innovation and commercial application of pharmaceutical technology. It has geographic areas in the Chinese Mainland and Overseas.

Executives

Jpmorgan Chase & Co.	2201 Interest of corporation controlled by you
Citigroup Inc.	2201 Interest of corporation controlled by you
Schroders Plc	2102 Investment manager
Norges Bank	2101 Beneficial owner
Fmr Llc	2201 Interest of corporation controlled by you
Fidelity Investment Trust	2101 Beneficial owner
Springhill Fund Asset Management (hk) Company Limited	2102 Investment manager
Springhill Fund Limited	2201 Interest of corporation controlled by you
Springhill Global Feeder Fund Limited	2201 Interest of corporation controlled by you
Springhill Master Fund Limited	2101 Beneficial owner
Morgan Stanley	2201 Interest of corporation controlled by you
Hhlr Advisors, Ltd.	2102 Investment manager
Hhlr Fund, L.p.	2101 Beneficial owner
Jpmorgan Asset Management (asia Pacific) Limited	2102 Investment manager
Fidelity Management & Research Company Llc

Asymchem Laboratories Tianjin Co Headlines

No Headlines